| Amgen (AMGN) |
United States |
$127.577B |
14.95 |
| Gilead Sciences (GILD) |
United States |
$100.276B |
10.00 |
| Celgene (CELG) |
United States |
$62.176B |
12.36 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$46.157B |
150.94 |
| Illumina (ILMN) |
United States |
$45.170B |
63.75 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$39.415B |
23.40 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$30.182B |
25.12 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$18.147B |
0.00 |
| Incyte (INCY) |
United States |
$14.916B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$10.764B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$10.592B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$8.999B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$8.874B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$8.869B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$8.516B |
68.69 |
| QIAGEN (QGEN) |
Netherlands |
$8.376B |
28.01 |
| Exact Sciences (EXAS) |
United States |
$8.135B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$6.980B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.332B |
25.70 |
| Bio-Techne Corp (TECH) |
United States |
$5.718B |
39.22 |
| Integra LifeSciences Holdings (IART) |
United States |
$5.531B |
29.69 |
| Galapagos (GLPG) |
Belgium |
$5.232B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$4.830B |
64.78 |
| Immunomedics (IMMU) |
United States |
$4.299B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$4.215B |
0.00 |
| MorphoSys AG Unsponsored ADR (MOR) |
Germany |
$4.149B |
0.00 |
| Array BioPharma (ARRY) |
United States |
$3.558B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.349B |
22.12 |
| Spark Therapeutics (ONCE) |
United States |
$3.191B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.993B |
36.29 |
| Ascendis Pharma (ASND) |
Denmark |
$2.980B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$2.978B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.970B |
0.00 |
| Medicines (MDCO) |
United States |
$2.927B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$2.845B |
17.41 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.831B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$2.795B |
0.00 |
| CRISPR THERAPTC (CRSP) |
Switzerland |
$2.762B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$2.727B |
34.86 |
| Halozyme Therapeutics (HALO) |
United States |
$2.521B |
38.91 |
| REGENXBIO (RGNX) |
United States |
$2.515B |
58.33 |
| Akcea Therapeutics (AKCA) |
United States |
$2.496B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$2.440B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$2.281B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$2.194B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.179B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.160B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$2.129B |
0.00 |
| Repligen (RGEN) |
United States |
$2.094B |
66.56 |
| MyoKardia (MYOK) |
United States |
$2.009B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$1.989B |
0.00 |
| Genomic Health (GHDX) |
United States |
$1.966B |
347.38 |
| Insmed (INSM) |
United States |
$1.947B |
0.00 |
| Cambrex (CBM) |
United States |
$1.857B |
17.08 |
| AnaptysBio (ANAB) |
United States |
$1.788B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$1.751B |
0.00 |
| Aimmune Therapeutics (AIMT) |
United States |
$1.686B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.673B |
0.00 |
| IMMURON LTD (IMRN) |
Australia |
$1.571B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$1.560B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$1.558B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.533B |
0.00 |
| Audentes Therapeutics (BOLD) |
United States |
$1.470B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$1.460B |
0.00 |
| BIOHAVEN PHARM (BHVN) |
United States |
$1.438B |
0.00 |
| Innoviva (INVA) |
United States |
$1.437B |
10.53 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.422B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$1.375B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$1.351B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$1.336B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.322B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$1.312B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.293B |
0.00 |
| Lion Biotechnologies (IOVA) |
United States |
$1.282B |
0.00 |
| Cellectis (CLLS) |
France |
$1.273B |
0.00 |
| Retrophin (RTRX) |
United States |
$1.262B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$1.255B |
0.00 |
| Zai Lab Unsponsored ADR (ZLAB) |
China |
$1.219B |
0.00 |
| Athenex (ATNX) |
United States |
$1.197B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$1.182B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$1.118B |
0.00 |
| NeoGenomics (NEO) |
United States |
$1.113B |
230.17 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.109B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.095B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$1.079B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.059B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$1.045B |
0.00 |
| DBV Technologies (DBVT) |
France |
$1.037B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$1.027B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.975B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.960B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.942B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$0.880B |
0.00 |
| AUTOLUS THERAPT (AUTL) |
United Kingdom |
$0.877B |
0.00 |
| Amarin (AMRN) |
Ireland |
$0.836B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.836B |
17.12 |
| InflaRx (IFRX) |
Germany |
$0.819B |
0.00 |
| Heska (HSKA) |
United States |
$0.803B |
61.50 |
| Inotek Pharmaceuticals (RCKT) |
United States |
$0.787B |
0.00 |
| AVROBIO INC (AVRO) |
United States |
$0.785B |
0.00 |
| NuCana Sponsored ADR (NCNA) |
United Kingdom |
$0.776B |
0.00 |
| EIDOS THERAPEUT (EIDX) |
United States |
$0.775B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.764B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.762B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$0.749B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.676B |
0.00 |
| APTINYX INC (APTX) |
United States |
$0.676B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$0.666B |
0.00 |
| Kura Oncology (KURA) |
United States |
$0.664B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.660B |
0.00 |
| UROGEN PHARMA (URGN) |
Israel |
$0.660B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.648B |
0.00 |
| UNITY Biotechnology (UBX) |
|
$0.635B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.623B |
0.00 |
| Geron (GERN) |
United States |
$0.621B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.613B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.607B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$0.607B |
0.00 |
| Tigenix (TIG) |
Belgium |
$0.605B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.588B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$0.583B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.582B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.580B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.561B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.554B |
0.00 |
| Nightstar Therapeutics Sponsored ADR (NITE) |
United States |
$0.554B |
0.00 |
| Keryx Biopharmaceuticals (KERX) |
United States |
$0.539B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.535B |
0.00 |
| Novavax (NVAX) |
United States |
$0.531B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.512B |
20.30 |
| Arcus Biosciences (RCUS) |
United States |
$0.509B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.487B |
0.00 |
| MAGENTA THERAPT (MGTA) |
United States |
$0.482B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.480B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.477B |
0.00 |
| Verastem (VSTM) |
United States |
$0.462B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.457B |
0.00 |
| Evelo Biosciences (EVLO) |
United States |
$0.445B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.439B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.427B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.417B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.409B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.406B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.393B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.390B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.386B |
3.94 |
| MiMedx (MDXG) |
United States |
$0.379B |
16.24 |
| Mersana Therapeutics (MRSN) |
United States |
$0.377B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.373B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.369B |
0.00 |
| Vericel (VCEL) |
United States |
$0.367B |
0.00 |
| Clementia Pharmaceuticals (CMTA) |
Canada |
$0.357B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.353B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.349B |
0.00 |
| GTx (GTXI) |
United States |
$0.348B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.338B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$0.337B |
0.00 |
| Vital Therapies (VTL) |
United States |
$0.335B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.331B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.324B |
0.00 |
| Sienna Biopharmaceuticals (SNNA) |
United States |
$0.323B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.308B |
0.00 |
| Peregrine Pharmaceuticals (CDMO) |
United States |
$0.306B |
0.00 |
| KEZAR LIFE SCI (KZR) |
United States |
$0.305B |
0.00 |
| BioTime (BTX) |
United States |
$0.305B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.303B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.294B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.292B |
0.00 |
| Biofrontera AG Sponsored ADR (BFRA) |
Germany |
$0.288B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.285B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.284B |
0.00 |
| MEIRAGTX HLDGS (MGTX) |
United States |
$0.284B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.281B |
0.00 |
| Athersys (ATHX) |
United States |
$0.276B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.268B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.263B |
0.00 |
| Axovant Sciences (AXON) |
United Kingdom |
$0.259B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.258B |
0.00 |
| ResTORbio (TORC) |
United States |
$0.243B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.241B |
0.00 |
| NantKwest (NK) |
United States |
$0.236B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.234B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.232B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.228B |
0.00 |
| Allena Pharmaceuticals (ALNA) |
United States |
$0.227B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.226B |
0.00 |
| MannKind (MNKD) |
United States |
$0.225B |
0.00 |
| Celcuity (CELC) |
United States |
$0.225B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.224B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.223B |
17.90 |
| Cohbar (CWBR) |
United States |
$0.223B |
0.00 |
| Agenus (AGEN) |
United States |
$0.223B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.210B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.209B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.205B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.204B |
0.00 |
| XOMA (XOMA) |
United States |
$0.202B |
15.35 |
| Mustang Bio (MBIO) |
United States |
$0.200B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.199B |
7.69 |
| Erytech Pharma SA Sponsored ADR (ERYP) |
|
$0.194B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.194B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$0.190B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.182B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.182B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.180B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$0.178B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.175B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.172B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.172B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.169B |
0.00 |
| Monster Digital (INNT) |
United States |
$0.169B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.166B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.164B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.163B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.160B |
0.00 |
| Bellerophon Therapeutics (BLPH) |
United States |
$0.157B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.153B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.152B |
0.00 |
| Intec Pharma (NTEC) |
Israel |
$0.149B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.148B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.142B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.142B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.139B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.139B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.139B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.139B |
0.00 |
| Cerecor (CERC) |
United States |
$0.137B |
21.80 |
| Pfenex (PFNX) |
United States |
$0.128B |
0.00 |
| Motif Bio Plc (MTFB) |
United States |
$0.128B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.126B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.121B |
0.00 |
| Eiger BioPharmaceuticals (EIGR) |
United States |
$0.116B |
0.00 |
| PSivida (EYPT) |
United States |
$0.115B |
0.00 |
| Gemphire Therapeutics (GEMP) |
United States |
$0.112B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.111B |
0.00 |
| Aptose Biosciences (APTO) |
Canada |
$0.110B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.107B |
0.00 |
| Tapimmune (TPIV) |
United States |
$0.104B |
0.00 |
| Trevena (TRVN) |
United States |
$0.104B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.101B |
0.00 |
| Asterias Biotherapeutics (AST) |
United States |
$0.097B |
0.00 |
| GENPREX INC (GNPX) |
United States |
$0.097B |
0.00 |
| Ophthotech (OPHT) |
United States |
$0.096B |
0.66 |
| Sophiris Bio (SPHS) |
United States |
$0.095B |
0.00 |
| Eleven Biotherapeutics (SESN) |
United States |
$0.094B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.092B |
0.00 |
| OncoMed Pharmaceuticals (OMED) |
United States |
$0.092B |
0.00 |
| Alcobra (ARCT) |
Israel |
$0.089B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.087B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.085B |
0.00 |
| Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.085B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.083B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.082B |
0.00 |
| Axsome Therapeutics (AXSM) |
United States |
$0.081B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.080B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.080B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.076B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.075B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.074B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.073B |
0.00 |
| ENTERA BIO LTD (ENTX) |
Israel |
$0.072B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.072B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.071B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.069B |
0.00 |
| Histogenics (HSGX) |
United States |
$0.069B |
0.00 |
| OncoSec Medical (ONCS) |
United States |
$0.068B |
0.00 |
| Novelion Therapeutics (NVLN) |
Canada |
$0.067B |
0.00 |
| Aileron Therapeutics (ALRN) |
United States |
$0.067B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.064B |
0.00 |
| Neothetics (EVFM) |
United States |
$0.064B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.063B |
0.00 |
| VolitionRX (VNRX) |
Singapore |
$0.061B |
0.00 |
| Curis (CRIS) |
United States |
$0.056B |
0.00 |
| Celsion (CLSN) |
United States |
$0.053B |
0.00 |
| Caladrius Biosciences (CLBS) |
United States |
$0.053B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.052B |
0.00 |
| Rexahn Pharmaceuticals (RNN) |
United States |
$0.048B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.048B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.047B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.046B |
0.00 |
| AZURRX BIOPHARM (AZRX) |
United States |
$0.045B |
0.00 |
| Proteon Therapeutics (PRTO) |
United States |
$0.044B |
0.00 |
| Arsanis (ASNS) |
United States |
$0.043B |
0.00 |
| BiondVax Pharmaceuticals (BVXV) |
Israel |
$0.042B |
0.00 |
| CytRx (CYTR) |
United States |
$0.041B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.040B |
0.00 |
| Cellect Biotechnology (APOP) |
Israel |
$0.040B |
0.00 |
| BioPharmX (BPMX) |
United States |
$0.038B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.037B |
0.00 |
| OvaScience (OVAS) |
United States |
$0.033B |
0.00 |
| Edge Therapeutics (EDGE) |
United States |
$0.032B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.032B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.031B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.031B |
0.00 |
| Oncobiologics (ONS) |
United States |
$0.028B |
0.00 |
| Synthetic Biologics (SYN) |
United States |
$0.027B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.027B |
0.00 |
| Vical (VICL) |
United States |
$0.026B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.026B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.025B |
0.00 |
| RestorGenex (DFFN) |
United States |
$0.024B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.022B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.021B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.021B |
0.00 |
| Prana Biotechnology (PRAN) |
Australia |
$0.020B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.020B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.019B |
0.00 |
| Neuralstem (CUR) |
United States |
$0.018B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.018B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.018B |
0.00 |
| AmpliPhi Biosciences (APHB) |
United States |
$0.018B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.017B |
0.00 |
| Flex Pharma (FLKS) |
United States |
$0.015B |
0.00 |
| Cerulean Pharma (DARE) |
United States |
$0.014B |
0.00 |
| Hemispherx BioPharma (HEB) |
United States |
$0.014B |
0.00 |
| Fibrocell Science Inc (FCSC) |
United States |
$0.013B |
0.00 |
| Therapix Biosciences (TRPX) |
Israel |
$0.012B |
5.84 |
| Alliqua BioMedical (ALQA) |
United States |
$0.011B |
0.00 |
| ContraVir Pharmaceuticals Inc (CTRV) |
United States |
$0.010B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.010B |
0.00 |
| IBio (IBIO) |
United States |
$0.010B |
0.00 |
| ImmunoCellular Therapeutics (IMUC) |
United States |
$0.010B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.010B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.010B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.009B |
0.00 |
| ARCA Biopharma (ABIO) |
United States |
$0.008B |
0.00 |
| Immune Pharmaceuticals (IMNP) |
United States |
$0.007B |
0.00 |
| Cytori Therapeutics Inc (CYTX) |
United States |
$0.006B |
0.00 |
| Stellar Biotechnologies (SBOT) |
United States |
$0.006B |
0.00 |
| Oragenics (OGEN) |
United States |
$0.004B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.004B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.002B |
0.00 |
